{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:22:52Z","timestamp":1744172572592,"version":"3.40.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11739-022-02989-9","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T10:05:39Z","timestamp":1651226739000},"page":"1845-1847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3673-2030","authenticated-orcid":false,"given":"Luca","family":"Bollo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-0523","authenticated-orcid":false,"given":"Francesca","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8645-1763","authenticated-orcid":false,"given":"Damiano","family":"Paolicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-8946","authenticated-orcid":false,"given":"Maria","family":"Trojano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-1731","authenticated-orcid":false,"given":"Pietro","family":"Iaffaldano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"issue":"1","key":"2989_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40263-019-00691-7","volume":"34","author":"D Paolicelli","year":"2020","unstructured":"Paolicelli D, Manni A, Iaffaldano A, Trojano M (2020) Efficacy and safety of oral therapies for relapsing-remitting multiple sclerosis. CNS Drugs gennaio 34(1):65\u201392","journal-title":"CNS Drugs gennaio"},{"issue":"4","key":"2989_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2016.21","volume":"12","author":"A Winkelmann","year":"2016","unstructured":"Winkelmann A, Loebermann M, Reisinger EC, Hartung H-P, Zettl UK (2016) Disease-modifying therapies and infectious risks in multiple sclerosis. Nat Rev Neurol aprile 12(4):217\u2013233","journal-title":"Nat Rev Neurol aprile"},{"key":"2989_CR3","first-page":"175628642091500","volume":"13","author":"R Gold","year":"2020","unstructured":"Gold R, Arnold DL, Bar-Or A, Fox RJ, Kappos L, Chen C et al (2020) Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years\u2019 follow-up of DEFINE, CONFIRM, and ENDORSE. Ther Adv Neurol Disord 13:1756286420915005","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"2989_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40263-020-00714-8","volume":"34","author":"G Boffa","year":"2020","unstructured":"Boffa G, Bruschi N, Cellerino M, Lapucci C, Novi G, Sbragia E et al (2020) Fingolimod and dimethyl-fumarate-derived lymphopenia is not associated with short-term treatment response and risk of infections in a real-life MS population. CNS Drugs aprile 34(4):425\u2013432","journal-title":"CNS Drugs aprile"},{"issue":"8","key":"2989_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1177\/1352458520977132","volume":"27","author":"T Kim","year":"2021","unstructured":"Kim T, Croteau D, Brinker A, Jones DE, Lee PR, Kortepeter CM (2021) Expanding spectrum of opportunistic infections associated with dimethyl fumarate. Mult Scler luglio 27(8):1301\u20131305","journal-title":"Mult Scler luglio"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-02989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-022-02989-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-02989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T16:25:43Z","timestamp":1744129543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-022-02989-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2989"],"URL":"https:\/\/doi.org\/10.1007\/s11739-022-02989-9","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MT has served on Scientific Advisory Boards for Biogen, Novartis, Roche, Merck, and Genzyme; has received speaker honoraria from Biogen Idec, Merck, Roche, Teva, Sanofi-Genzyme, and Novartis; and has received research grants for her Institution from Biogen Idec, Merck, Roche, and Novartis. PI has served on scientific advisory boards for Biogen Idec and has received funding for travel and\/or speaker honoraria from Sanofi-Aventis, Biogen Idec, Teva, and Novartis. DP received advisory board membership, speaker\u2019s honoraria, travel support, research grants, consulting fees, or clinical trial support from Almirall, Bayer Schering, Biogen, Celgene, Excemed, Genzyme, Merck, Mylan, Novartis, Sanofi, Roche, and Teva. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"The patient has consented to the submission of the case report to the\u00a0journal and she signed an informed consent regarding publishing her clinical data. The adverse event was reported\u00a0to the Italian Medicines Agency (AIFA).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}